133 related articles for article (PubMed ID: 1899534)
1. The action of nitric oxide in the perfused human fetal-placental circulation.
Myatt L; Brewer A; Brockman DE
Am J Obstet Gynecol; 1991 Feb; 164(2):687-92. PubMed ID: 1899534
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation.
Myatt L; Brewer AS; Langdon G; Brockman DE
Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):224-30. PubMed ID: 1733199
[TBL] [Abstract][Full Text] [Related]
3. S-nitrosothiols as vasodilators: implications regarding tolerance to nitric oxide-containing vasodilators.
Henry PJ; Drummer OH; Horowitz JD
Br J Pharmacol; 1989 Nov; 98(3):757-66. PubMed ID: 2511992
[TBL] [Abstract][Full Text] [Related]
4. The interaction of nitric oxide and superoxide in the human fetal-placental vasculature.
Holcberg G; Kossenjans W; Miodovnik M; Myatt L
Am J Obstet Gynecol; 1995 Aug; 173(2):528-33. PubMed ID: 7544069
[TBL] [Abstract][Full Text] [Related]
5. Evidence for inhibition by endothelium-derived relaxing factor of thromboxane A2 receptor-mediated vasoconstriction in the fetal vessels of the human perfused placenta.
Gude NM; Boura AL; King RG; Brennecke SP; Jamal OS; Smith R; Walters WA
Placenta; 1992; 13(6):597-605. PubMed ID: 1296206
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the pharmacological actions of nitrovasodilators by methylene blue and pyocyanin.
Gryglewski RJ; Zembowicz A; Salvemini D; Taylor GW; Vane JR
Br J Pharmacol; 1992 Aug; 106(4):838-45. PubMed ID: 1327388
[TBL] [Abstract][Full Text] [Related]
7. Effects of nitrovasodilators on the human fetal-placental circulation in vitro.
Zhang XQ; Kwek K; Read MA; Donoghue JF; Walters WA
Placenta; 2001 Apr; 22(4):337-46. PubMed ID: 11286570
[TBL] [Abstract][Full Text] [Related]
8. Novel S-nitrosothiols do not engender vascular tolerance and remain effective in glyceryl trinitrate-tolerant rat femoral arteries.
Miller MR; Megson IL; Roseberry MJ; Mazzei FA; Butler AR; Webb DJ
Eur J Pharmacol; 2000 Sep; 403(1-2):111-9. PubMed ID: 10969151
[TBL] [Abstract][Full Text] [Related]
9. NO is more important than PGI2 in maintaining low vascular tone in feto-placental vessels.
Chaudhuri G; Cuevas J; Buga GM; Ignarro LJ
Am J Physiol; 1993 Dec; 265(6 Pt 2):H2036-43. PubMed ID: 8285242
[TBL] [Abstract][Full Text] [Related]
10. Shear stress may stimulate release and action of nitric oxide in the human fetal-placental vasculature.
Wieczorek KM; Brewer AS; Myatt L
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):708-13. PubMed ID: 7573230
[TBL] [Abstract][Full Text] [Related]
11. Role of nitric oxide synthesis in the regulation of coronary vascular tone in the isolated perfused rabbit heart.
Smith RE; Palmer RM; Bucknall CA; Moncada S
Cardiovasc Res; 1992 May; 26(5):508-12. PubMed ID: 1446321
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human placental fetal vessel tone: role of nitric oxide.
King RG; Gude NM; Di Iulio JL; Brennecke SP
Reprod Fertil Dev; 1995; 7(6):1407-11. PubMed ID: 8743139
[TBL] [Abstract][Full Text] [Related]
13. Alpha-atrial natriuretic peptide-induced attenuation of vasoconstriction in the fetal circulation of the human isolated perfused placenta.
Stebbing PN; Gude NM; King RG; Brennecke SP
J Perinat Med; 1996; 24(3):253-60. PubMed ID: 8827574
[TBL] [Abstract][Full Text] [Related]
14. Effects of nitric oxide donors and inhibitors of nitric oxide signalling on endothelin- and serotonin-induced contractions in human placental arteries.
Sand AE; Andersson E; Fried G
Acta Physiol Scand; 2002 Mar; 174(3):217-23. PubMed ID: 11906320
[TBL] [Abstract][Full Text] [Related]
15. Time-dependent increase in nitric oxide formation concurrent with vasodilation induced by sodium nitroprusside, 3-morpholinosydnonimine, and S-nitroso-N-acetylpenicillamine but not by glyceryl trinitrate.
Marks GS; McLaughlin BE; Jimmo SL; Poklewska-Koziell M; Brien JF; Nakatsu K
Drug Metab Dispos; 1995 Nov; 23(11):1248-52. PubMed ID: 8591726
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.
Salvemini D; Currie MG; Mollace V
J Clin Invest; 1996 Jun; 97(11):2562-8. PubMed ID: 8647949
[TBL] [Abstract][Full Text] [Related]
17. Expression of nitric oxide synthase in normal and preeclamptic placental tissue and effects of glyceryl trinitrate and shear stress on placental blood flow.
Poranen AK; Aubry J; Kujari H; Ekblad U
Acta Obstet Gynecol Scand; 1998 Jul; 77(6):594-7. PubMed ID: 9688234
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nitric oxide-induced vasodilation by gap junction inhibitors: a potential role for a cGMP-independent nitric oxide pathway.
Javid PJ; Watts SW; Webb RC
J Vasc Res; 1996; 33(5):395-404. PubMed ID: 8862145
[TBL] [Abstract][Full Text] [Related]
19. Positive inotropic effect of exogenous and endogenous NO in hypertrophic rat hearts.
Kojda G; Kottenberg K; Stasch JP; Schrör K; Noack E
Br J Pharmacol; 1997 Nov; 122(5):813-20. PubMed ID: 9384495
[TBL] [Abstract][Full Text] [Related]
20. Endogenous nitric oxide attenuates ethanol-induced vasoconstriction in the human placenta.
Acevedo CG; Huambachano AM; Bravo I; Contreras E
Gynecol Obstet Invest; 1997; 44(3):153-6. PubMed ID: 9359639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
